Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$7.65 - $15.51 $1.32 Million - $2.67 Million
-172,432 Reduced 92.72%
13,548 $200,000
Q3 2022

Nov 10, 2022

BUY
$8.63 - $15.52 $98,778 - $177,641
11,446 Added 6.56%
185,980 $1.65 Million
Q2 2022

Aug 12, 2022

SELL
$8.59 - $20.77 $1.15 Million - $2.78 Million
-133,967 Reduced 43.43%
174,534 $2.21 Million
Q1 2022

May 16, 2022

BUY
$15.52 - $35.65 $1.68 Million - $3.86 Million
108,370 Added 54.15%
308,501 $5.84 Million
Q4 2021

Feb 14, 2022

BUY
$28.89 - $35.33 $922,631 - $1.13 Million
31,936 Added 18.99%
200,131 $7.02 Million
Q3 2021

Nov 12, 2021

BUY
$35.66 - $42.94 $1.46 Million - $1.76 Million
40,927 Added 32.16%
168,195 $6.16 Million
Q2 2021

Aug 16, 2021

SELL
$23.7 - $39.27 $2.17 Million - $3.6 Million
-91,624 Reduced 41.86%
127,268 $5 Million
Q1 2021

May 14, 2021

SELL
$27.01 - $36.8 $283,280 - $385,958
-10,488 Reduced 4.57%
218,892 $6.18 Million
Q4 2020

Feb 12, 2021

BUY
$27.51 - $34.36 $56,643 - $70,747
2,059 Added 0.91%
229,380 $7.35 Million
Q3 2020

Nov 13, 2020

SELL
$25.8 - $34.61 $268,500 - $360,186
-10,407 Reduced 4.38%
227,321 $7.34 Million
Q2 2020

Aug 12, 2020

BUY
$17.65 - $28.05 $265,773 - $422,376
15,058 Added 6.76%
237,728 $6.56 Million
Q1 2020

May 13, 2020

SELL
$15.19 - $29.51 $51,402 - $99,861
-3,384 Reduced 1.5%
222,670 $3.98 Million
Q4 2019

Feb 12, 2020

SELL
$17.17 - $25.95 $46,994 - $71,025
-2,737 Reduced 1.2%
226,054 $5.67 Million
Q3 2019

Nov 12, 2019

BUY
$17.84 - $22.69 $974,438 - $1.24 Million
54,621 Added 31.36%
228,791 $4.08 Million
Q2 2019

Aug 14, 2019

SELL
$22.0 - $31.78 $172,722 - $249,504
-7,851 Reduced 4.31%
174,170 $3.83 Million
Q1 2019

May 14, 2019

BUY
$21.27 - $30.58 $29,033 - $41,741
1,365 Added 0.76%
182,021 $5.57 Million
Q4 2018

Feb 13, 2019

BUY
$23.09 - $37.69 $4.17 Million - $6.81 Million
180,656 New
180,656 $4.17 Million

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $2.47B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.